Table 1.
ADAS-cog | HippoV | CSF tau | AV45 | ||
---|---|---|---|---|---|
ADAS-cog | 0 | −0.23286 | 0.04579 | 0.11301 | −0.08587 |
HippoV | 0 | 0 | 0 | −0.06553 | −0.42319 |
CSF tau | 0 | 0 | 0 | 0.01371 | 0.10595 |
AV45 | 0 | 0 | 0 | 0 | 0.19057 |
This table summarizes the model parameters and estimated by linear mixed effects models. The elements of A quantify how much the biomarkers in the rows of the table change depending on the biomarkers in the columns. The elements of in the last column quantify how much the biomarkers in the rows of the table change depending on time. ADAS-cog, cognitive Alzheimer’s disease assessment scale; HippoV, hippocampal volume; CSF tau, corticospinal fluid total tau; AV45, florbetapir amyloid-PET score.